Skip to main content
. 2021 Jun 22;12(13):1296–1308. doi: 10.18632/oncotarget.27988

Figure 4. KMT2D-regulating pathways.

Figure 4

(A) The kinases AKT and SGK1 phosphorylate KMT2D to reduce its methyltransferase activity. (B) miRNAs (e.g., miR-217) targets KMT2D mRNA to reduce KMT2D expression. (C) KMT2D expression is repressed by DNA CpG methylation. (D) The E3 ligase FBXW7 targets KMT2D for protein degradation.